Complementary Interventions (CIV) HIV Reporting FY12 Q2

Transcription

1 Complementary Interventions (CIV) HIV Reporting FY Q Fiscal Year 0 quarter was the second quarter that Complementary Interventions tracked HIV Reimbursable Reporting. There were countries that submitted reports. The following countries reported use of HIV reimbursable funds:. East India. El Salvador 3. Ethiopia 4. Ghana 5. Haiti 6. India 7. Kenya 8. Rwanda 9. Tanzania 0. Togo. Uganda The following report illustrates the following: Q Beneficiaries tested for HIV for the First Time, and Q:Q comparison Q Beneficiaries tested positive for HIV, and Q:Q comparison Q Recipients of Anti- retroviral Therapy, and Q:Q comparison Q Deaths from HIV/AIDS related causes, and Q:Q comparison Q- Q Overall results in table format As this is only the second quarter of data collection, it is important recognize that the field offices are still in the early phases of data collection and further analysis needs to take place.

2 Q Beneficiaries Tested for HIV for the First Time Q:Q Beneficiaries Tested for HIV for the First Time CSP: Pregnant Caregiver Q Q Q3 Q4 54,966 beneficiaries were tested for HIV for the first time during this quarter (an increase of 8% from Q) Q Beneficiaries Tested Positive for HIV Q:Q Beneficiaries Tested Positive for HIV CSP: Pregnant Caregiver Q Q Q3 Q4 008 beneficiaries tested positive for HIV (an increase of 7% from Q)

3 Q Recipients of Anti-retroviral Therapy Q:Q Recipiant of Anti-retroviral Therapy CSP: Non- Primary Q Q Q3 Q ,45 beneficiaries were the recipients of Anti- retroviral Therapy (an increase of 47% from Q) Q Deaths from HIV/AIDS Related Causes Q:Q Deaths from HIV/AIDS Related Causes CSP: Pregnant Caregiver Q Q Q3 Q4 There were 5 deaths from HIV/AIDS related causes (an increase of 5% from Q) Beneficiaries Tested for HIV for the First Time Q Q % Q Q%

4 56 % 398 3% CSP: Pregnant Caregiver % 88 0% 85 % 44 % 87 % 7 0% 43 0% 9 0% % % % % 378 3% 464 % 70 0% 0% TOTAL % % Tested Positive for HIV Q Q % Q Q% 89 0% 48 % CSP: Pregnant Caregiver 0 % 3 0% 5 % 8 0% 35 4% 0% 3 0% 0% % % 30 35% 96 65% 86 9% 4 % 0% 0% TOTAL 94 00% %

5 Recipient of Anti- retroviral Therapy Q Q % Q Q% 43 % 50 % 4 0% 3 0% 7 0% 0% 0 0% 3 0% % 98 5% % 73 8% 3 4% 35 % 0% 0% TOTAL % % CSP Pregnant Caregivers who tested positive for HIV and are on ART for Prevention of Mother to Child Transmission (PMTCT) 0 3 Q Q Deaths from HIV/AIDS Related Causes Q Q % Q Q% 0 0% 8% CSP: Pregnant Caregiver 0 0% 0 0% 5% 8% 5% 4% 0 0% 0 0% 0 50% 6 4% 6 30% 48% 0% 8% 0 0% 0 0% TOTAL 0 00% 5 00%

6 Q Forecast Q Actual Expense Percent Increase/ Decrease from forcasted amount Q3 Forecast Q3 Actual Expense Percent Increase/ Percent Increase/ Decrease from Decrease in forcasted forcasted amount amount from Q to Q3 Burkina Faso $ 38,5 $ 0,73-9% $ % East India $ - $ - 0% $ - 0% El Salvador $ - $ - 0% $ 500 0% East Indonesia $ 0,000 $ % $ % Ethiopia $ 95,4 $ 4,967-7% $ 38,930-9% Ghana $ 0,05 $ 3,83-6% $ 4,957-5% Haiti $ 0,000 $ % $ 0,000 0% India $,000 $,4 4% $,500 50% Kenya $ 8,000 $ 4,879-37% $ 73,834-4% Rwanda $ 85,000 $ 8,667 - % $ 5,63-8% Tanzania $ 448,535 $ 380,853-5% $ 39,37-3% Togo $ 95,555 $ % $ 99,78 4% Uganda $ 36,95 $ 48,36 8% $ 73,775-6% TOTAL $,60,956 $,54,7 - % $,45,83 $ - - %